Vasoactive Amines and Inotropic Agents

  • Keith P. Lewis
  • R. Mauricio Gonzalez


Maintaining hemodynamic stability is the primary goal of clinicians who care for critically ill patients. This requires knowledge of the anatomy and physiology of the autonomic nervous system, the cardiovascular system, and their interactions. This chapter reviews the autonomic innervation of the heart and peripheral circulation and the cardiovascular effects of the vasoactive amines and various inotropes.


Sympathetic Nervous System Renal Blood Flow Coronary Blood Flow Inotropic Agent Parasympathetic Nervous System 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Lawson NW, Meyer DJ. Autonomic nervous system: physiology and pharmacology. In: Barash PG, Cullen BF, Stoelting RK, eds. Clinical Anesthesia. Philadelphia: Lippincot-Raven, 1997: 243–309.Google Scholar
  2. 2.
    Lin SY, Sheu WH, LeeWJ, Song YM, Chen YT. Trp64Arg polymorphism of the beta 3-adrenergic receptor gene is associated with increased plasma leptin levels in obese Chinese women. Chung Hua I Hsueh Tsa Chih -Chinese Medical Journal 1999; 62: 569–76.Google Scholar
  3. 3.
    Shihara N, Yasuda K, Moritani T, Ue H, Adachi T, Tanaka H, Tsuda K, Seino Y. The association between Trp64Arg polymorphism of the beta 3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab 1999; 84: 1623–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Vendrell J, Gutierrez C, Broch M, Fernandez-Real JM, Aguilar C, Richart C. Beta 3adrenoreceptor gene polymorphism and leptin. Lack of relationship in type 2 diabetic patients. Clin Endocrinol (Oxf) 1998; 49: 679–83.CrossRefGoogle Scholar
  5. 5.
    Hoffman BB, Lefkowitz RJ. Cathecolamines, sympathomimetic drugs, and adrenergic receptor antagonists. In: Hardman JG, Limbird LE, editors-in-chief. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, 1996: 199–248.Google Scholar
  6. 6.
    Oliver G, Schaffer EA. The physiological action of extract of the suprarenal capsules. J Physiol (Lond) 1895; 18: 230–76.Google Scholar
  7. 7.
    Stoelting RK. Pharmacology and physiology in anesthetic practice. Philadelphia: Lippincott-Raven, 1999: 259–277.Google Scholar
  8. 8.
    DiSesa VJ. The rational selection of inotropic drugs in cardiac surgery. J Cardiac Surg 1987; 2: 385–406.CrossRefGoogle Scholar
  9. 9.
    Struthers AD, Reid JL. The role of adrenal medullary cathecolamines in potassium homeostasis. Clin Sci 1984; 66: 377–82.PubMedGoogle Scholar
  10. 10.
    Sumikawa K, Hayashi Y, Yamatodani A, Yoshiya I. Contribution of the lungs to the clearance of exogenous dopamine in humans. Anesth Analg 1991; 72: 622–6.PubMedCrossRefGoogle Scholar
  11. 11.
    Goldberg LI, Rajfer SI. Dopamine receptors: applications in clinical cardiology. Circulation 1985; 72: 245–8.PubMedCrossRefGoogle Scholar
  12. 12.
    Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994; 120: 744–7.PubMedGoogle Scholar
  13. 13.
    Hilberman M, Maseda J, Stinson EB, Derby GC, Spencer RJ, Miller DC, Oyer PE, Myers BD. The diuretic properties of dopamine in patients after open-heart operation. Anesthesiology 1984: 61: 489–494.PubMedCrossRefGoogle Scholar
  14. 14.
    Goldberg LI. Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972; 24: 1–29.PubMedGoogle Scholar
  15. 15.
    Thompson BT, Cockrill BA. Renal-dose dopamine: a siren song? Lancet 1994; 334: 7–8.CrossRefGoogle Scholar
  16. 16.
    Van den Berghe G, de Zegher F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1580–90.PubMedCrossRefGoogle Scholar
  17. 17.
    Van den Berghe G, de Zegher F, Wouters P, Schietz M, Verwaest C, Ferdinande P, Lauwers P. Dehydroepiandrosterone sulphate in critical illness: effect of dopamine. Clin Endocrinol (Oxf) 1995; 43: 457–63.CrossRefGoogle Scholar
  18. 18.
    Devins SS, Miller A, Herndon BL, O’Toole L, Reisz G. Effects of dopamine on T Lymphocyte proliferative responses and serum prolactin concentrations in critically ill patients. Crit Care Med 1992; 20: 1644–9.PubMedCrossRefGoogle Scholar
  19. 19.
    DiSesa VJ, Brown E, Mudge GH Jr, Collins JJ Jr, Cohn LH. Hemodynamic comparison of dopamine and dobutamine in the postoperative volume-loaded, pressure-loaded, and normal ventricle. J Thorac Cardiovasc Surg 1982; 83: 256–63.PubMedGoogle Scholar
  20. 20.
    Berendes E, Mollhoff T, Van Aken H, Schmidt C, Erren M, Deng MC, Weyand M, Loick HM. Effects of dopexamine on creatinine clearance, systemic inflammation and splanchnic oxygenation in patients undergoing coronary artery bypass grafting. Anesth Analg 1997; 84: 950–7.PubMedGoogle Scholar
  21. 21.
    Butterworth JF 4th, Piccione W Jr, Berrizbeitia LD, Dance G, Shemin RJ, Cohn LH. Augmentation of venous return by adrenergic agonists during spinal anesthesia. Anesth Analg 1986; 65: 612–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Stoelting RK. Pharmacology and physiology in anesthetic practice. Philadelphia: Lippincot- Raven, 1999: 284–5.Google Scholar
  23. 23.
    Lewis KP. Early intervention of inotropic support in facilitating weaning from cardiopulmonary bypass: the New England Deaconess Hospital experience. J Cardiothorac Vasc Anesth 1993; 7: 405.CrossRefGoogle Scholar
  24. 24.
    Lewis KP. The Use of amrinone in noncardiac anesthesia. J Cardiothorac Anesth 1990; 4 (suppl 5): 34–40.CrossRefGoogle Scholar
  25. 25.
    Leier CV. General overview and update of positive inotropic therapy. Am J Med 1986; 81 (4C): 40–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Feneck RO. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 1992; 6: 563–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • Keith P. Lewis
    • 1
  • R. Mauricio Gonzalez
    • 1
  1. 1.Boston University Medical CenterBostonUSA

Personalised recommendations